EUPRAXIA PHARMACEUTICALS INC
Q2 2024 13F Holders
Symbol
EPRX
CUSIP
29842P105
Type
Equity
Class
COM
Num filings
10
Total reported value, excl. options
$4.44 M
Compare 2024 Q2 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type